Director of Halozyme Therapeutics, Inc. (NASDAQ:HALO), Henderson Jeffrey William, sells 24,498 shares worth $981,757

According to Halozyme Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 25 06:59 PM, company Director, Henderson Jeffrey William disclosed selling 24,498 shares at a cost of $40.08. At the time of this transaction (Nov 25), this trade was worth $981,757 in total. As of Nov 25, Henderson Jeffrey William now owns 47,609 shares in total worth about $1,958,634.26.

For the last few recent trades made by Halozyme Therapeutics, Inc. (NASDAQ:HALO) Director, Henderson Jeffrey William, we have the following information:

Posted by George Daniels on Thursday November 26 2020, 1:57 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0